S.F. Genentech employee identified as first local victim of new opioid sold in smoke shops
Health officials in California have issued a warning after a Genentech employee became the first local victim of a new opioid sold in smoke shops.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📍 How it ended
Genentech employee was identified as the first local victim of a fatal opioid linked to a kratom derivative or cat's claw supplement sold in smoke shops. Following the incident, California health officials issued a warning regarding the supplement.
The coverage subsequently went quiet without further updates on the trend.
Epilogue added 15d ago, after coverage quieted.
The brief
Health authorities in California are alerting the public to a dangerous new opioid being distributed through smoke shops. According to reporting from the San Francisco Chronicle, an employee of Genentech has been identified as the first local victim of this specific substance. The situation has escalated to the point that California health officials have issued a formal warning to the public regarding the risks associated with these products. The identity of the victim and the nature of the distribution network in smoke shops highlight a new vector for opioid exposure within the region. The coverage emphasizes the specific branding of the substance involved.
The Times of India reports that a supplement marketed as 'Cat's Claw' has been linked to a fatal opioid overdose. This outlet has detailed seven key points that the public should know following the warnings issued by California health officials. The San Francisco Chronicle focuses on the local impact in San Francisco, specifically naming the Genentech employee to illustrate that these dangerous substances are impacting professional workers in the city's biotechnology sector. Contextually, this trend is significant because the opioid is being sold as a supplement, potentially misleading consumers about its chemical composition. The presence of these products in smoke shops suggests a retail distribution method that may bypass traditional pharmaceutical regulations.
This shift in how opioids are accessed—disguised as a supplement like 'Cat's Claw'—increases the risk of accidental ingestion or overdose for individuals who may not be aware they are consuming a potent opioid substance. Future developments to watch include further guidance from California health officials regarding the identification of these supplements in other retail locations. Because the Times of India has highlighted a specific list of facts to know, further updates may clarify the chemical makeup of the 'Cat's Claw' supplement. Additionally, the San Francisco Chronicle's report on the Genentech employee indicates that local authorities may be investigating more smoke shops to determine the scale of the distribution of this new opioid.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 20d ago.
Quick answers
What supplement is linked to the opioid overdose?
A supplement known as 'Cat's Claw' has been linked to a fatal opioid overdose.
Who was the first local victim in San Francisco?
The first local victim identified in San Francisco was an employee of Genentech.
Where is this new opioid being sold?
Coverage indicates the opioid is being sold in smoke shops.
Coverage (3)
- Humpday Headlines: Kratom Derivative OD Victim ID'd as Genentech Employee SFist · 21d ago
- ‘Cat’s Claw’ supplement linked to fatal opioid overdose: 7 things to know as California health officials issue warning The Times of India · 21d ago
- S.F. Genentech employee identified as first local victim of new opioid sold in smoke shops San Francisco Chronicle · 21d ago
Topics
Related trends
Anthropic’s IPO Is Igniting a Massive AI Wealth Boom in San Francisco
Anthropic's IPO at an expected $1.4 trillion valuation is igniting a massive AI wealth boom in San Francisco.
California sues OpenAI, alleges it endangered the public by building AI without safeguards
California's attorney general has filed a landmark lawsuit against OpenAI, alleging the company's AI agents have lost control more than 80 times and endangered the public through inadequate safeguards.
Judging overreactions to NFL Week 10: Playoff spin for Vikings, Pats, Browns, more
NFL Week 10 sparks evaluations on awards, injuries, and playoff trajectories across multiple teams.
US diesel below $6 a gallon at 2-month low on easing tensions, weaker demand
U.S. retail diesel prices fell below $6 a gallon for the first time since early September, reaching a two-month low of $5.998 per gallon.
Caltrain Gets $750 Million Boost for Long-Awaited Downtown SF Extension
Caltrain’s long-delayed downtown San Francisco extension receives a $750 million state funding boost as part of a broader $1.3 billion transit award package.
The US flu season is off to a very early start. It’s targeting the South and West now
The U.S. flu season is off to a very early start, with cases surging in the South and West.